NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
02/17/2026
Back to search
Official data from USPTO
AUCTA PHARMACEUTICALS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
AUCTA PHARMACEUTICALS
ST13
US500000097276478Class
5
Filing
97276478
Registration
8145708
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
42
Latest update
02/17/2026
Classification
Registered
Trademark type
Word
Nice classes
5
Filing date
02/21/2022
Registration date
02/17/2026
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/17/2026
Last transaction
02/17/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
02/16/2024
First use in commerce
02/16/2024
Drawing code
4
Owner type
03
Owner location
Piscataway, NJ, US
Examiner
HERR, JENNA FRANCES
Law office
L10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Aucta Pharmaceuticals, Inc.
Representatives
Michael J. Leonard FOX ROTHSCHILD LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for use in the treatment of seizures, bipolar disorders, depression and neurofibromatosis; Pharmaceutical preparations for the prevention and treatment of central nervous system disorders, neurological diseases and disorders, neurodegenerative disorders, and depression
Publications
History of USPTO decisions and trademark events.
42 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
02/17/2026
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
01/26/2026
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
01/26/2026
SUPC
STATEMENT OF USE PROCESSING COMPLETE
12/29/2025
IUAF
USE AMENDMENT FILED
12/23/2025
EISU
TEAS STATEMENT OF USE RECEIVED
12/23/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
11/06/2025
EX5G
SOU EXTENSION 5 GRANTED
11/05/2025
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
11/04/2025
EEXT
SOU TEAS EXTENSION RECEIVED
06/05/2025
EXT5
SOU EXTENSION 5 FILED
06/04/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/03/2025
EX4G
SOU EXTENSION 4 GRANTED
12/05/2024
EXT4
SOU EXTENSION 4 FILED
12/05/2024
EEXT
SOU TEAS EXTENSION RECEIVED
12/04/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/13/2024
EX3G
SOU EXTENSION 3 GRANTED
06/04/2024
EXT3
SOU EXTENSION 3 FILED
06/04/2024
EEXT
SOU TEAS EXTENSION RECEIVED
06/04/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/29/2023
EX2G
SOU EXTENSION 2 GRANTED
12/27/2023
EXT2
SOU EXTENSION 2 FILED
12/27/2023
EEXT
SOU TEAS EXTENSION RECEIVED
12/27/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/29/2023
EX1G
SOU EXTENSION 1 GRANTED
06/27/2023
EXT1
SOU EXTENSION 1 FILED
06/27/2023
EEXT
SOU TEAS EXTENSION RECEIVED
06/27/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
12/27/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/01/2022
PUBO
PUBLISHED FOR OPPOSITION
11/01/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/12/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/26/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/21/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/21/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/21/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/21/2022
GNRT
NON-FINAL ACTION E-MAILED
03/21/2022
CNRT
NON-FINAL ACTION WRITTEN
03/21/2022
DOCK
ASSIGNED TO EXAMINER
03/21/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/24/2022
NWAP
NEW APPLICATION ENTERED
02/24/2022
Continuous trademark protection
Get notified about every new filing that threatens AUCTA PHARMACEUTICALS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.